623 related articles for article (PubMed ID: 16820562)
1. Clinical application of tissue engineered human heart valves using autologous progenitor cells.
Cebotari S; Lichtenberg A; Tudorache I; Hilfiker A; Mertsching H; Leyh R; Breymann T; Kallenbach K; Maniuc L; Batrinac A; Repin O; Maliga O; Ciubotaru A; Haverich A
Circulation; 2006 Jul; 114(1 Suppl):I132-7. PubMed ID: 16820562
[TBL] [Abstract][Full Text] [Related]
2. Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells.
Sodian R; Lueders C; Kraemer L; Kuebler W; Shakibaei M; Reichart B; Daebritz S; Hetzer R
Ann Thorac Surg; 2006 Jun; 81(6):2207-16. PubMed ID: 16731156
[TBL] [Abstract][Full Text] [Related]
3. Flow-dependent re-endothelialization of tissue-engineered heart valves.
Lichtenberg A; Cebotari S; Tudorache I; Sturz G; Winterhalter M; Hilfiker A; Haverich A
J Heart Valve Dis; 2006 Mar; 15(2):287-93; discussion 293-4. PubMed ID: 16607913
[TBL] [Abstract][Full Text] [Related]
4. Mid-term clinical results using a tissue-engineered pulmonary valve to reconstruct the right ventricular outflow tract during the Ross procedure.
Dohmen PM; Lembcke A; Holinski S; Kivelitz D; Braun JP; Pruss A; Konertz W
Ann Thorac Surg; 2007 Sep; 84(3):729-36. PubMed ID: 17720368
[TBL] [Abstract][Full Text] [Related]
5. Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells.
Fang NT; Xie SZ; Wang SM; Gao HY; Wu CG; Pan LF
Chin Med J (Engl); 2007 Apr; 120(8):696-702. PubMed ID: 17517187
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for early pulmonary valve replacement after valve disruption in congenital pulmonary stenosis and tetralogy of Fallot.
Kogon B; Plattner C; Kirshbom P; Kanter K; Leong T; Lyle T; Jennings S; McConnell M; Book W
J Thorac Cardiovasc Surg; 2009 Jul; 138(1):103-8. PubMed ID: 19577064
[TBL] [Abstract][Full Text] [Related]
7. From stem cells to viable autologous semilunar heart valve.
Sutherland FW; Perry TE; Yu Y; Sherwood MC; Rabkin E; Masuda Y; Garcia GA; McLellan DL; Engelmayr GC; Sacks MS; Schoen FJ; Mayer JE
Circulation; 2005 May; 111(21):2783-91. PubMed ID: 15927990
[TBL] [Abstract][Full Text] [Related]
8. In vivo autologous recellularization of a tissue-engineered heart valve: are bone marrow mesenchymal stem cells the best candidates?
Vincentelli A; Wautot F; Juthier F; Fouquet O; Corseaux D; Marechaux S; Le Tourneau T; Fabre O; Susen S; Van Belle E; Mouquet F; Decoene C; Prat A; Jude B
J Thorac Cardiovasc Surg; 2007 Aug; 134(2):424-32. PubMed ID: 17662783
[TBL] [Abstract][Full Text] [Related]
9. A new treatment option for pulmonary valvar insufficiency: first experiences with implantation of a self-expanding stented valve without use of cardiopulmonary bypass.
Schreiber C; Hörer J; Vogt M; Fratz S; Kunze M; Galm C; Eicken A; Lange R
Eur J Cardiothorac Surg; 2007 Jan; 31(1):26-30. PubMed ID: 17113305
[TBL] [Abstract][Full Text] [Related]
10. A tissue engineered heart valve implanted in a juvenile sheep model.
Dohmen PM; Ozaki S; Nitsch R; Yperman J; Flameng W; Konertz W
Med Sci Monit; 2003 Apr; 9(4):BR97-BR104. PubMed ID: 12709659
[TBL] [Abstract][Full Text] [Related]
11. Preclinical testing of tissue-engineered heart valves re-endothelialized under simulated physiological conditions.
Lichtenberg A; Tudorache I; Cebotari S; Suprunov M; Tudorache G; Goerler H; Park JK; Hilfiker-Kleiner D; Ringes-Lichtenberg S; Karck M; Brandes G; Hilfiker A; Haverich A
Circulation; 2006 Jul; 114(1 Suppl):I559-65. PubMed ID: 16820637
[TBL] [Abstract][Full Text] [Related]
12. Construction of autologous human heart valves based on an acellular allograft matrix.
Cebotari S; Mertsching H; Kallenbach K; Kostin S; Repin O; Batrinac A; Kleczka C; Ciubotaru A; Haverich A
Circulation; 2002 Sep; 106(12 Suppl 1):I63-I68. PubMed ID: 12354711
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary valve repair late after right ventricular outflow tract reconstruction in children and adolescents.
Park CS; Lee CH; Lee YO; Kim GB; Kim JT; Kim YJ
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):906-9. PubMed ID: 20197352
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous tissue-engineered pulmonary valved stent implantation.
Lutter G; Metzner A; Jahnke T; Bombien R; Boldt J; Iino K; Cremer J; Stock UA
Ann Thorac Surg; 2010 Jan; 89(1):259-63. PubMed ID: 20103248
[TBL] [Abstract][Full Text] [Related]
15. Ten years of clinical results with a tissue-engineered pulmonary valve.
Dohmen PM; Lembcke A; Holinski S; Pruss A; Konertz W
Ann Thorac Surg; 2011 Oct; 92(4):1308-14. PubMed ID: 21958777
[TBL] [Abstract][Full Text] [Related]
16. Orthotopic replacement of the aortic valve with decellularized allograft in a sheep model.
Baraki H; Tudorache I; Braun M; Höffler K; Görler A; Lichtenberg A; Bara C; Calistru A; Brandes G; Hewicker-Trautwein M; Hilfiker A; Haverich A; Cebotari S
Biomaterials; 2009 Oct; 30(31):6240-6. PubMed ID: 19703713
[TBL] [Abstract][Full Text] [Related]
17. Living autologous heart valves engineered from human prenatally harvested progenitors.
Schmidt D; Mol A; Breymann C; Achermann J; Odermatt B; Gössi M; Neuenschwander S; Prêtre R; Genoni M; Zund G; Hoerstrup SP
Circulation; 2006 Jul; 114(1 Suppl):I125-31. PubMed ID: 16820561
[TBL] [Abstract][Full Text] [Related]
18. Reconstruction of the pulmonary valve and outflow tract. A report of 25 cases.
Trusler GA; Iyengar SR; Mustard WT
J Thorac Cardiovasc Surg; 1973 Feb; 65(2):245-51. PubMed ID: 4685005
[No Abstract] [Full Text] [Related]
19. Prevention of device-related tissue damage during percutaneous deployment of tissue-engineered heart valves.
Stock UA; Degenkolbe I; Attmann T; Schenke-Layland K; Freitag S; Lutter G
J Thorac Cardiovasc Surg; 2006 Jun; 131(6):1323-30. PubMed ID: 16733165
[TBL] [Abstract][Full Text] [Related]
20. Autologous human tissue-engineered heart valves: prospects for systemic application.
Mol A; Rutten MC; Driessen NJ; Bouten CV; Zünd G; Baaijens FP; Hoerstrup SP
Circulation; 2006 Jul; 114(1 Suppl):I152-8. PubMed ID: 16820565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]